Tag: PTSD
-
![BetterLife Pharma (BETR.C) products show promise, but how’s their timing?]()
BetterLife Pharma (BETR.C) products show promise, but how’s their timing?
Drug science is all about timing. You can either take a preexisting molecule, which has benefits for alternative indications rather than what it’s originally on shelves for, and you after proving that it has these benefits during the regulatory dance, you take it to a new market, rebrand it and resell it. Easy. Or you…
-
Numinus Wellness (NUMI.V) to partner on MDMA psychotherapy trial for PTSD patients
If this was a 1990’s news website we’d be putting all sorts of animated siren gifs all over the top of this piece because, I ain’t gonna lie: It’s a big one. Numinus Wellness (NUMI.V), who we’ve been eyeing at a distance for some time because we love shrooms as an industry but don’t trust…
-
![Patriot One (PAT.T) develops A.I.-driven “fight detector” for Corrections Canada]()
Patriot One (PAT.T) develops A.I.-driven “fight detector” for Corrections Canada
On March 9, 2020 Patriot One (PAT.T) announced that it has been awarded a contract for the PATSCAN Multi-Sensor Covert Threat Detection Platform by Innovation Solutions Canada (ISC) for Correctional Service Canada (CSC). The PATSCAN Multi-Sensor Covert Threat Detection Platform is a layered multi-sensor platform – integrated with A.I Managed security system to detect and combat…
-
![Patriot One (PAT.T) signs $780,000 contract with Canadian military]()
Patriot One (PAT.T) signs $780,000 contract with Canadian military
“We’ve been working with Canada’s ISC division and Canadian Department of National Defense (DND) over the past year on this critical program for personnel and asset protection while at port around the world,” stated Martin Cronin, CEO and President of Patriot One
-
A Closer Look: ThinkMyco pushes the button on magic mushroom market
Psilocybin and other psychedelics are forcing their way out of prohibition as potentially viable treatments for not only depression and anxiety but also Alzheimer’s and other neurodegenerative diseases plaguing millions in North America alone. In the end, psilocybin solutions address a $300 billion dollar psychotherapy and wellness global market. Shroom Stocks’ own Ethan Reyes spoke…
